Cytisine for smoking cessation
- PMID: 29759967
- PMCID: PMC5953578
- DOI: 10.1503/cmaj.171371
Cytisine for smoking cessation
Conflict of interest statement
Competing interests: Taleen Karnieg and Xiang Wang have no financial or business relationships with manufacturers of pharmaceutical preparations of cytisine or pharmacies stocking these products. They did not receive any compensation for the writing of this article.
References
-
- Rigotti NA. Cytisine — a tobacco treatment hiding in plain sight. N Engl J Med 2014;371:2429–30. - PubMed
-
- Jeong SH, Newcombe D, Sheridan J, et al. Pharmacokinetics of cytisine, an α4 β2 nicotinic receptor partial agonist, in healthy smokers following a single dose. Drug Test Anal 2015; 7: 475–82. - PubMed
-
- Walker N, Bullen C, Barnes J, et al. Getting cytisine licensed for use world-wide: a call to action. Addiction 2016;111: 1895–8. - PubMed
-
- West R, Zatonski W, Cedzynska M, et al. Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med 2011;365: 1193–200. - PubMed
-
- Walker N, Howe C, Glover M, et al. Cytisine versus nicotine for smoking cessation. N Engl J Med 2014;371:2353–62. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical